Skip to main content
Top
Published in: Arthritis Research & Therapy 6/2007

Open Access 01-12-2006 | Research article

Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections

Authors: Siva Kanangat, Arnold Postlethwaite, Karen Hasty, Andrew Kang, Mark Smeltzer, Whitney Appling, Dennis Schaberg

Published in: Arthritis Research & Therapy | Issue 6/2007

Login to get access

Abstract

Infections of body tissue by Staphylococcus aureus are quickly followed by degradation of connective tissue. Patients with rheumatoid arthritis are more prone to S. aureus-mediated septic arthritis. Various types of collagen form the major structural matrix of different connective tissues of the body. These different collagens are degraded by specific matrix metalloproteinases (MMPs) produced by fibroblasts, other connective tissue cells, and inflammatory cells that are induced by interleukin-1 (IL-1) and tumor necrosis factor (TNF). To determine the host's contribution in the joint destruction of S. aureus-mediated septic arthritis, we analyzed the MMP expression profile in human dermal and synovial fibroblasts upon exposure to culture supernatant and whole cell lysates of S. aureus. Human dermal and synovial fibroblasts treated with cell lysate and filtered culture supernatants had significantly enhanced expression of MMP-1, MMP-2, MMP-3, MMP-7, MMP-10, and MMP-11 compared with the untreated controls (p < 0.05). In the S. aureus culture supernatant, the MMP induction activity was identified to be within the molecular-weight range of 30 to >50 kDa. The MMP expression profile was similar in fibroblasts exposed to a combination of IL-1/TNF. mRNA levels of several genes of the mitogen-activated protein kinase (MAPK) signal transduction pathway were significantly elevated in fibroblasts treated with S. aureus cell lysate and culture supernatant. Also, tyrosine phosphorylation was significantly higher in fibroblasts treated with S. aureus components. Tyrosine phosphorylation and MAPK gene expression patterns were similar in fibroblasts treated with a combination of IL-1/TNF and S. aureus. Mutants lacking staphylococcal accessory regulator (Sar) and accessory gene regulator (Agr), which cause significantly less severe septic arthritis in murine models, were able to induce expression of several MMP mRNA comparable with that of their isogenic parent strain but induced notably higher levels of tissue inhibitors of metalloproteinases (TIMPs). To our knowledge, this is the first report of induction of multiple MMP/TIMP expression from human dermal and synovial fibroblasts upon S. aureus treatment. We propose that host-derived MMPs contribute to the progressive joint destruction observed in S. aureus-mediated septic arthritis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Josefsson E, Tarkowski A: Staphylococcus aureus -induced inflammation and bone destruction in experimental models of septic arthritis. J Periodontal Res. 1999, 34: 387-392. 10.1111/j.1600-0765.1999.tb02271.x.CrossRefPubMed Josefsson E, Tarkowski A: Staphylococcus aureus -induced inflammation and bone destruction in experimental models of septic arthritis. J Periodontal Res. 1999, 34: 387-392. 10.1111/j.1600-0765.1999.tb02271.x.CrossRefPubMed
2.
go back to reference Xu Y, Rivas JM, Brown EL, Liang X, Hook M: Virulence potential of the staphylococcal adhesin CNA in experimental arthritis is determined by its affinity for collagen. J Infect Dis. 2004, 189: 2323-2333. 10.1086/420851.CrossRefPubMed Xu Y, Rivas JM, Brown EL, Liang X, Hook M: Virulence potential of the staphylococcal adhesin CNA in experimental arthritis is determined by its affinity for collagen. J Infect Dis. 2004, 189: 2323-2333. 10.1086/420851.CrossRefPubMed
3.
go back to reference Dubost JJ, Soubrier M, Sauvezie B: Pyogenic arthritis in adults. Joint Bone Spine. 2000, 67: 11-21.PubMed Dubost JJ, Soubrier M, Sauvezie B: Pyogenic arthritis in adults. Joint Bone Spine. 2000, 67: 11-21.PubMed
4.
go back to reference Mor A, Mitnick HJ, Greene JB, Azar N, Budnah R, Fetto J: Relapsing oligoarticular septic arthritis during etanercept treatment of rheumatoid arthritis. J Clin Rheumatol. 2006, 12: 87-89. 10.1097/01.rhu.0000209881.43764.5f.CrossRefPubMed Mor A, Mitnick HJ, Greene JB, Azar N, Budnah R, Fetto J: Relapsing oligoarticular septic arthritis during etanercept treatment of rheumatoid arthritis. J Clin Rheumatol. 2006, 12: 87-89. 10.1097/01.rhu.0000209881.43764.5f.CrossRefPubMed
5.
go back to reference Abid N, Bhatti M, Azharuddin M, Islam M: Septic arthritis in a tertiary care hospital. J Pak Med Assoc. 2006, 56: 95-98.PubMed Abid N, Bhatti M, Azharuddin M, Islam M: Septic arthritis in a tertiary care hospital. J Pak Med Assoc. 2006, 56: 95-98.PubMed
6.
go back to reference Cleeman E, Auerback JD, Klingenstein GG, Flatow EL: Septic arthritis of the glenohumeral joint: a review of 23 cases. J Surg Orthop Adv. 2005, 14: 102-107.PubMed Cleeman E, Auerback JD, Klingenstein GG, Flatow EL: Septic arthritis of the glenohumeral joint: a review of 23 cases. J Surg Orthop Adv. 2005, 14: 102-107.PubMed
7.
go back to reference Moumile K, Merckx J, Glorion C, Pouliquen JC, Berche P, Ferroni A: Bacterial aetiology of acute osteoarticular infections in children. Acta Paediatr. 2005, 94: 419-422. 10.1080/08035250410023278.CrossRefPubMed Moumile K, Merckx J, Glorion C, Pouliquen JC, Berche P, Ferroni A: Bacterial aetiology of acute osteoarticular infections in children. Acta Paediatr. 2005, 94: 419-422. 10.1080/08035250410023278.CrossRefPubMed
8.
go back to reference Goergens ED, McEvoy A, Watson M, Barrett IR: Acute osteomyelitis and septic arthritis in children. J Paediatr Child Health. 2005, 41: 59-62. 10.1111/j.1440-1754.2005.00538.x.CrossRefPubMed Goergens ED, McEvoy A, Watson M, Barrett IR: Acute osteomyelitis and septic arthritis in children. J Paediatr Child Health. 2005, 41: 59-62. 10.1111/j.1440-1754.2005.00538.x.CrossRefPubMed
9.
go back to reference Elkington PT, O'Kane CM, Friedland JS: The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol. 2005, 142: 12-20. 10.1111/j.1365-2249.2005.02840.x.PubMedCentralCrossRefPubMed Elkington PT, O'Kane CM, Friedland JS: The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol. 2005, 142: 12-20. 10.1111/j.1365-2249.2005.02840.x.PubMedCentralCrossRefPubMed
10.
go back to reference Burrage PS, Mix KS, Brinckerhoff CE: Matrix metalloproteinases: role in arthritis. Front Biosci. 2006, 11: 529-543.CrossRefPubMed Burrage PS, Mix KS, Brinckerhoff CE: Matrix metalloproteinases: role in arthritis. Front Biosci. 2006, 11: 529-543.CrossRefPubMed
11.
go back to reference Akashi A, Ono S, Kuwano K, Arai S: Proteins of 30 and 36 kilodaltons, membrane constituents of the Staphylococcus aureus L form, induce production of tumor necrosis factor alpha and activate the human immunodeficiency virus type 1 long terminal repeat. Infect Immun. 1996, 64: 3267-3272.PubMedCentralPubMed Akashi A, Ono S, Kuwano K, Arai S: Proteins of 30 and 36 kilodaltons, membrane constituents of the Staphylococcus aureus L form, induce production of tumor necrosis factor alpha and activate the human immunodeficiency virus type 1 long terminal repeat. Infect Immun. 1996, 64: 3267-3272.PubMedCentralPubMed
12.
go back to reference Yao L, Lowy FD, Berman JW: Interleukin-8 gene expression in Staphylococcus aureus -infected endothelial cells. Infect Immun. 1996, 64: 3407-3409.PubMedCentralPubMed Yao L, Lowy FD, Berman JW: Interleukin-8 gene expression in Staphylococcus aureus -infected endothelial cells. Infect Immun. 1996, 64: 3407-3409.PubMedCentralPubMed
13.
go back to reference Megyeri K, Mandi Y, Degre M, Rosztoczy I: Induction of cytokine production by different Staphylococcal strains. Cytokine. 2002, 19: 206-212. 10.1006/cyto.2002.0876.CrossRefPubMed Megyeri K, Mandi Y, Degre M, Rosztoczy I: Induction of cytokine production by different Staphylococcal strains. Cytokine. 2002, 19: 206-212. 10.1006/cyto.2002.0876.CrossRefPubMed
14.
go back to reference Matsubara M, Harada D, Manabe H, Hasegawa K: Staphylococcus aureus peptidoglycan stimulates granulocyte macrophage colony-stimulating factor production from human epidermal keratinocytes via mitogen-activated protein kinases. FEBS Lett. 2004, 566: 195-200. 10.1016/j.febslet.2004.04.028.CrossRefPubMed Matsubara M, Harada D, Manabe H, Hasegawa K: Staphylococcus aureus peptidoglycan stimulates granulocyte macrophage colony-stimulating factor production from human epidermal keratinocytes via mitogen-activated protein kinases. FEBS Lett. 2004, 566: 195-200. 10.1016/j.febslet.2004.04.028.CrossRefPubMed
15.
go back to reference Mengshol JA, Mix KS, Brinckerhoff CE: Matrix metalloproteinases as therapeutic targets in arthritic diseases: bull's-eye or missing the mark?. Arthritis Rheum. 2002, 46: 13-20. 10.1002/1529-0131(200201)46:1<13::AID-ART497>3.0.CO;2-S.CrossRefPubMed Mengshol JA, Mix KS, Brinckerhoff CE: Matrix metalloproteinases as therapeutic targets in arthritic diseases: bull's-eye or missing the mark?. Arthritis Rheum. 2002, 46: 13-20. 10.1002/1529-0131(200201)46:1<13::AID-ART497>3.0.CO;2-S.CrossRefPubMed
16.
go back to reference Williams RJ, Smith RL, Schurman DJ: Septic arthritis. Staphylococcal induction of chondrocyte proteolytic activity. Arthritis Rheum. 1990, 33: 533-541.CrossRefPubMed Williams RJ, Smith RL, Schurman DJ: Septic arthritis. Staphylococcal induction of chondrocyte proteolytic activity. Arthritis Rheum. 1990, 33: 533-541.CrossRefPubMed
17.
go back to reference Liu Zai-Qing, Deng Guo-Min, Foster Simon, Tarkowski Andrej: Staphylococcal peptidoglycans induce arthritis. Arthritis Res. 2001, 3: 375-380. 10.1186/ar330.PubMedCentralCrossRefPubMed Liu Zai-Qing, Deng Guo-Min, Foster Simon, Tarkowski Andrej: Staphylococcal peptidoglycans induce arthritis. Arthritis Res. 2001, 3: 375-380. 10.1186/ar330.PubMedCentralCrossRefPubMed
18.
go back to reference Kyburz D, Rethage J, Seibl R, Lauener R, Gay RE, Carson DA, Gay S: Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling. Arthritis Rheum. 2003, 48: 642-650. 10.1002/art.10848.CrossRefPubMed Kyburz D, Rethage J, Seibl R, Lauener R, Gay RE, Carson DA, Gay S: Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling. Arthritis Rheum. 2003, 48: 642-650. 10.1002/art.10848.CrossRefPubMed
19.
go back to reference Blevins JS, Elasri MO, Allmendinger SD, Beenken KE, Skinner RA, Thomas JR, Smeltzer MS: Role of sarA in the pathogenesis of Staphylococcus aureus musculoskeletal infection. Infect Immun. 2003, 71: 516-523. 10.1128/IAI.71.1.516-523.2003.PubMedCentralCrossRefPubMed Blevins JS, Elasri MO, Allmendinger SD, Beenken KE, Skinner RA, Thomas JR, Smeltzer MS: Role of sarA in the pathogenesis of Staphylococcus aureus musculoskeletal infection. Infect Immun. 2003, 71: 516-523. 10.1128/IAI.71.1.516-523.2003.PubMedCentralCrossRefPubMed
20.
go back to reference Lohse A, Michel F, Auge B, Toussirot E, Wendling D: Pneumococcal polyarticular septic arthritis in a patient with rheumatoid arthritis. Rev Rhum Engl Ed. 1999, 66: 344-346.PubMed Lohse A, Michel F, Auge B, Toussirot E, Wendling D: Pneumococcal polyarticular septic arthritis in a patient with rheumatoid arthritis. Rev Rhum Engl Ed. 1999, 66: 344-346.PubMed
21.
go back to reference Youssef PP, York JR: Septic arthritis: a second decade of experience. Aust N Z J Med. 1994, 24: 307-311.CrossRefPubMed Youssef PP, York JR: Septic arthritis: a second decade of experience. Aust N Z J Med. 1994, 24: 307-311.CrossRefPubMed
22.
go back to reference Kanangat S, Bronze MS, Meduri GU, Postlethwaite A, Stentz F, Tolley E, Schaberg D: Enhanced extracellular growth of Staphylococcus aureus in the presence of selected linear peptide fragments of human interleukin (IL)-1beta and IL-1 receptor antagonist. J Infect Dis. 2001, 183: 65-69. 10.1086/317645.CrossRefPubMed Kanangat S, Bronze MS, Meduri GU, Postlethwaite A, Stentz F, Tolley E, Schaberg D: Enhanced extracellular growth of Staphylococcus aureus in the presence of selected linear peptide fragments of human interleukin (IL)-1beta and IL-1 receptor antagonist. J Infect Dis. 2001, 183: 65-69. 10.1086/317645.CrossRefPubMed
23.
go back to reference McLaughlin RA, Hoogewerf AJ: Interleukin-1beta-induced growth enhancement of Staphylococcus aureus occurs in biofilm but not planktonic cultures. Microb Pathog. 2006, 41: 67-79. 10.1016/j.micpath.2006.04.005.CrossRefPubMed McLaughlin RA, Hoogewerf AJ: Interleukin-1beta-induced growth enhancement of Staphylococcus aureus occurs in biofilm but not planktonic cultures. Microb Pathog. 2006, 41: 67-79. 10.1016/j.micpath.2006.04.005.CrossRefPubMed
24.
go back to reference Lee LYL, Hook M, Haviland D, Wetsel RA, Yonter EO, Syribeys P, Vernachio J, Brown EL: Inhibition of complement activation by a secreted Staphylococcal aureus protein. J Infect Dis. 2004, 190: 571-579. 10.1086/422259.CrossRefPubMed Lee LYL, Hook M, Haviland D, Wetsel RA, Yonter EO, Syribeys P, Vernachio J, Brown EL: Inhibition of complement activation by a secreted Staphylococcal aureus protein. J Infect Dis. 2004, 190: 571-579. 10.1086/422259.CrossRefPubMed
25.
go back to reference DiScipio RG, Schraufstatter IU, Sikora L, Zuraw BL, Sriramarao P: C5a mediates secretion and activation of matrix metalloproteinase 9 from human eosinophils and neutrophils. Int Immunopharmacol. 2006, 6: 1109-1118. 10.1016/j.intimp.2006.02.006.CrossRefPubMed DiScipio RG, Schraufstatter IU, Sikora L, Zuraw BL, Sriramarao P: C5a mediates secretion and activation of matrix metalloproteinase 9 from human eosinophils and neutrophils. Int Immunopharmacol. 2006, 6: 1109-1118. 10.1016/j.intimp.2006.02.006.CrossRefPubMed
26.
go back to reference Ren K, Bannan JD, Pancholi V, Cheung AL, Robbins JC, Fischetti VA, Zabriskie JB: Characterization and biological properties of a new staphylococcal exotoxin. J Exp Med. 1994, 180: 1675-1683. 10.1084/jem.180.5.1675.CrossRefPubMed Ren K, Bannan JD, Pancholi V, Cheung AL, Robbins JC, Fischetti VA, Zabriskie JB: Characterization and biological properties of a new staphylococcal exotoxin. J Exp Med. 1994, 180: 1675-1683. 10.1084/jem.180.5.1675.CrossRefPubMed
27.
go back to reference Su YC, Wong AC: Identification and purification of a new staphylococcal enterotoxin, H. Appl Environ Microbiol. 1995, 61: 1438-1443.PubMedCentralPubMed Su YC, Wong AC: Identification and purification of a new staphylococcal enterotoxin, H. Appl Environ Microbiol. 1995, 61: 1438-1443.PubMedCentralPubMed
28.
go back to reference Hussain M, Becker K, von Eiff C, Schrenzel J, Peters G, Herrmann M: Identification and characterization of a novel 38.5 kilodalton cell surface protein of Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and plasma proteins. J Bacteriol. 2001, 183: 6778-6786. 10.1128/JB.183.23.6778-6786.2001.PubMedCentralCrossRefPubMed Hussain M, Becker K, von Eiff C, Schrenzel J, Peters G, Herrmann M: Identification and characterization of a novel 38.5 kilodalton cell surface protein of Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and plasma proteins. J Bacteriol. 2001, 183: 6778-6786. 10.1128/JB.183.23.6778-6786.2001.PubMedCentralCrossRefPubMed
29.
go back to reference Calander AM, Jonsson IM, Kanth A, Arvidsson S, Shaw L, Foster SJ, Tarkowski A: Impact of staphylococcal protease expression on the outcome of infectious arthritis. Microbes Infect. 2004, 6: 202-206. 10.1016/j.micinf.2003.10.015.CrossRefPubMed Calander AM, Jonsson IM, Kanth A, Arvidsson S, Shaw L, Foster SJ, Tarkowski A: Impact of staphylococcal protease expression on the outcome of infectious arthritis. Microbes Infect. 2004, 6: 202-206. 10.1016/j.micinf.2003.10.015.CrossRefPubMed
30.
go back to reference Gjertsson I, Innocenti M, Matrisian LM, Tarkowski A: Metalloproteinase-7 contributes to joint destruction in Staphylococcus aureus induced arthritis. Microb Pathog. 2005, 38: 97-105. 10.1016/j.micpath.2004.12.005.CrossRefPubMed Gjertsson I, Innocenti M, Matrisian LM, Tarkowski A: Metalloproteinase-7 contributes to joint destruction in Staphylococcus aureus induced arthritis. Microb Pathog. 2005, 38: 97-105. 10.1016/j.micpath.2004.12.005.CrossRefPubMed
31.
go back to reference Wang YY, Myhre AE, Pettersen SJ, Dahle MK, Foster SJ, Thiemermann C, Bjornland K, Aasen AO, Wang JE: Peptidoglycan of Staphylococcus aureus induces enhanced levels of matrix metalloproteinase-9 in human blood originating from neutrophils. Shock. 2005, 24: 214-218. 10.1097/01.shk.0000174935.13786.6c.CrossRefPubMed Wang YY, Myhre AE, Pettersen SJ, Dahle MK, Foster SJ, Thiemermann C, Bjornland K, Aasen AO, Wang JE: Peptidoglycan of Staphylococcus aureus induces enhanced levels of matrix metalloproteinase-9 in human blood originating from neutrophils. Shock. 2005, 24: 214-218. 10.1097/01.shk.0000174935.13786.6c.CrossRefPubMed
32.
go back to reference Brenner DA, O'Hara M, Angel P, Chojkier M, Karin M: Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature. 1989, 337: 661-663. 10.1038/337661a0.CrossRefPubMed Brenner DA, O'Hara M, Angel P, Chojkier M, Karin M: Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature. 1989, 337: 661-663. 10.1038/337661a0.CrossRefPubMed
33.
go back to reference Unemori EN, Hibbs MS, Amento EP: Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest. 1991, 88: 1656-1662.PubMedCentralCrossRefPubMed Unemori EN, Hibbs MS, Amento EP: Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest. 1991, 88: 1656-1662.PubMedCentralCrossRefPubMed
34.
go back to reference Reunanen N, Westermarck J, Hakkinen L, Holmstrom TH, Elo I, Eriksson JE, Kahari VM: Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J Biol Chem. 1998, 273: 5137-5145. 10.1074/jbc.273.9.5137.CrossRefPubMed Reunanen N, Westermarck J, Hakkinen L, Holmstrom TH, Elo I, Eriksson JE, Kahari VM: Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J Biol Chem. 1998, 273: 5137-5145. 10.1074/jbc.273.9.5137.CrossRefPubMed
35.
go back to reference Lai WC, Zhou M, Shankavaram U, Peng G, Wahl LM: Differential regulation of lipopolysaccharide-induced monocyte matrix metalloproteinase (MMP)-1 and MMP-9 by p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J Immunol. 2003, 170: 6244-6249.CrossRefPubMed Lai WC, Zhou M, Shankavaram U, Peng G, Wahl LM: Differential regulation of lipopolysaccharide-induced monocyte matrix metalloproteinase (MMP)-1 and MMP-9 by p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J Immunol. 2003, 170: 6244-6249.CrossRefPubMed
36.
go back to reference Hultgren O, Eugster HP, Sedgwick JD, Korner H, Tarkowski A: TNF/lymphotoxin-alpha double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus. J Immunol. 1998, 161: 5937-5942.PubMed Hultgren O, Eugster HP, Sedgwick JD, Korner H, Tarkowski A: TNF/lymphotoxin-alpha double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus. J Immunol. 1998, 161: 5937-5942.PubMed
37.
go back to reference Kimura M, Matsukawa A, Ohkawara S, Takagi K, Yoshinaga M: Blocking of TNF-α and IL-1 inhibits leukocyte infiltration at early, but not at late stage of S. aureus -induced arthritis and the concomitant cartilage destruction in rabbits. Clin Immunol Immunopathol. 1997, 82: 18-25. 10.1006/clin.1996.4276.CrossRefPubMed Kimura M, Matsukawa A, Ohkawara S, Takagi K, Yoshinaga M: Blocking of TNF-α and IL-1 inhibits leukocyte infiltration at early, but not at late stage of S. aureus -induced arthritis and the concomitant cartilage destruction in rabbits. Clin Immunol Immunopathol. 1997, 82: 18-25. 10.1006/clin.1996.4276.CrossRefPubMed
38.
go back to reference Abdelnour A, Arvidson S, Bremell T, Ryden C, Tarkowski A: The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun. 1993, 61: 3879-3885.PubMedCentralPubMed Abdelnour A, Arvidson S, Bremell T, Ryden C, Tarkowski A: The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun. 1993, 61: 3879-3885.PubMedCentralPubMed
39.
go back to reference Cheung AL, Eberhardt KJ, Chung E, Yeaman MR, Sullam PM, Ramos M, Bayer AS: Diminished virulence of a sar-/agr-mutant of Staphylococcus aureus in the rabbit model of endocarditis. J Clin Investig. 1994, 94: 1815-1822.PubMedCentralCrossRefPubMed Cheung AL, Eberhardt KJ, Chung E, Yeaman MR, Sullam PM, Ramos M, Bayer AS: Diminished virulence of a sar-/agr-mutant of Staphylococcus aureus in the rabbit model of endocarditis. J Clin Investig. 1994, 94: 1815-1822.PubMedCentralCrossRefPubMed
40.
go back to reference Gillaspy AF, Hickmon SG, Skinner RA, Thomas JR, Nelson CL, Smeltzer MS: Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis. Infect Immun. 1995, 63: 3373-3380.PubMedCentralPubMed Gillaspy AF, Hickmon SG, Skinner RA, Thomas JR, Nelson CL, Smeltzer MS: Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis. Infect Immun. 1995, 63: 3373-3380.PubMedCentralPubMed
41.
go back to reference Nilsson IM, Bremell T, Ryden C, Cheung AL, Tarkowski A: Role of the staphylococcal accessory gene regulator (sar) in septic arthritis. Infect Immun. 1996, 64: 4438-4443.PubMedCentralPubMed Nilsson IM, Bremell T, Ryden C, Cheung AL, Tarkowski A: Role of the staphylococcal accessory gene regulator (sar) in septic arthritis. Infect Immun. 1996, 64: 4438-4443.PubMedCentralPubMed
42.
go back to reference Okamoto T, Akaike T, Suga M, Tanase S, Horie H, Miyajima S, Ando M, Ichinose Y, Maeda H: Activation of human matrix metalloproteinases by various bacterial proteinases. J Biol Chem. 1997, 272: 6059-6066. 10.1074/jbc.272.9.6059.CrossRefPubMed Okamoto T, Akaike T, Suga M, Tanase S, Horie H, Miyajima S, Ando M, Ichinose Y, Maeda H: Activation of human matrix metalloproteinases by various bacterial proteinases. J Biol Chem. 1997, 272: 6059-6066. 10.1074/jbc.272.9.6059.CrossRefPubMed
43.
go back to reference DeCarlo AA, Windsor LJ, Bodden MK, Harber GJ, Birkedal-Hansen B, Birkedal-Hansen H: Activation and novel processing of matrix metalloproteinases by a thiol-proteinase from the oral anaerobe Porphyromonas gingivalis. J Dent Res. 1997, 76: 1260-1270.CrossRefPubMed DeCarlo AA, Windsor LJ, Bodden MK, Harber GJ, Birkedal-Hansen B, Birkedal-Hansen H: Activation and novel processing of matrix metalloproteinases by a thiol-proteinase from the oral anaerobe Porphyromonas gingivalis. J Dent Res. 1997, 76: 1260-1270.CrossRefPubMed
44.
go back to reference Jonsson IM, Mazmanian SK, Schneewind O, Bremell T, Tarkowski A: The role of Staphylococcus aureus sortase A and sortase B in murine arthritis. Microbes Infect. 2003, 5: 775-780. 10.1016/S1286-4579(03)00143-6.CrossRefPubMed Jonsson IM, Mazmanian SK, Schneewind O, Bremell T, Tarkowski A: The role of Staphylococcus aureus sortase A and sortase B in murine arthritis. Microbes Infect. 2003, 5: 775-780. 10.1016/S1286-4579(03)00143-6.CrossRefPubMed
45.
go back to reference Jonsson IM, Arvidson S, Foster S, Tarkowski A: Sigma factor B and RsbU are required for virulence in Staphylococcus aureus -induced arthritis and sepsis. Infect Immun. 2004, 72: 6106-6111. 10.1128/IAI.72.10.6106-6111.2004.PubMedCentralCrossRefPubMed Jonsson IM, Arvidson S, Foster S, Tarkowski A: Sigma factor B and RsbU are required for virulence in Staphylococcus aureus -induced arthritis and sepsis. Infect Immun. 2004, 72: 6106-6111. 10.1128/IAI.72.10.6106-6111.2004.PubMedCentralCrossRefPubMed
46.
go back to reference Josefsson E, Juuti K, Bokarewa M, Kuusela P: The surface protein Pls of methicillin-resistant Staphylococcus aureus is a virulence factor in septic arthritis. Infect Immun. 2005, 73: 2812-2817. 10.1128/IAI.73.5.2812-2817.2005.PubMedCentralCrossRefPubMed Josefsson E, Juuti K, Bokarewa M, Kuusela P: The surface protein Pls of methicillin-resistant Staphylococcus aureus is a virulence factor in septic arthritis. Infect Immun. 2005, 73: 2812-2817. 10.1128/IAI.73.5.2812-2817.2005.PubMedCentralCrossRefPubMed
47.
go back to reference Tien I: Update on the management of skin, soft tissue, and osteoarticular infections in children. Curr Opin Pediatr. 2006, 18: 254-259. 10.1097/01.mop.0000193308.45333.11.CrossRefPubMed Tien I: Update on the management of skin, soft tissue, and osteoarticular infections in children. Curr Opin Pediatr. 2006, 18: 254-259. 10.1097/01.mop.0000193308.45333.11.CrossRefPubMed
48.
go back to reference Roberts S, Chambers S: Diagnosis and management of Staphylococcus aureus infections of the skin and soft tissue. Intern Med J. 2005, 35 (Suppl 2): S97-105. 10.1111/j.1444-0903.2005.00983.x.CrossRefPubMed Roberts S, Chambers S: Diagnosis and management of Staphylococcus aureus infections of the skin and soft tissue. Intern Med J. 2005, 35 (Suppl 2): S97-105. 10.1111/j.1444-0903.2005.00983.x.CrossRefPubMed
49.
go back to reference Seal J, Glynn L, Statter M, Liu D: A high prevalence of methicillin-resistant Staphylococcus aureus among surgically drained soft-tissue infections in pediatric patients. Pediatr Surg Int. 2006, 22: 683-687. 10.1007/s00383-006-1684-x.CrossRefPubMed Seal J, Glynn L, Statter M, Liu D: A high prevalence of methicillin-resistant Staphylococcus aureus among surgically drained soft-tissue infections in pediatric patients. Pediatr Surg Int. 2006, 22: 683-687. 10.1007/s00383-006-1684-x.CrossRefPubMed
50.
go back to reference Davis JS: Management of bone and joint infections due to Staphylococcus aureus. Intern Med J. 2005, 35 (Suppl 2): S79-96. 10.1111/j.1444-0903.2005.00982.x.CrossRefPubMed Davis JS: Management of bone and joint infections due to Staphylococcus aureus. Intern Med J. 2005, 35 (Suppl 2): S79-96. 10.1111/j.1444-0903.2005.00982.x.CrossRefPubMed
Metadata
Title
Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections
Authors
Siva Kanangat
Arnold Postlethwaite
Karen Hasty
Andrew Kang
Mark Smeltzer
Whitney Appling
Dennis Schaberg
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 6/2007
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2086

Other articles of this Issue 6/2007

Arthritis Research & Therapy 6/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.